Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Leukoaraiosis

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Leukoaraiosis in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Leukoaraiosis: Non-specific white matter changes in the BRAIN, often seen after age 65. Changes include loss of AXONS; MYELIN pallor, GLIOSIS, loss of ependymal cells, and enlarged perivascular spaces. Leukoaraiosis is a risk factor for DEMENTIA and CEREBROVASCULAR DISORDERS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zimmermann, J1
Friedli, N1
Bavato, F1
Stämpfli, P1
Coray, R1
Baumgartner, MR1
Grandgirard, D1
Leib, SL1
Opitz, A1
Seifritz, E1
Stock, AK1
Beste, C1
Cole, DM1
Quednow, BB1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Leukoaraiosis

ArticleYear
White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels.
    NeuroImage. Clinical, 2022, Volume: 36

    Topics: Anisotropy; Brain; Diffusion Tensor Imaging; Humans; Leukoaraiosis; N-Methyl-3,4-methylenedioxyamphe

2022